CIK 0001668243
- Non-accelerated filer
- Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 97707601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- 4 Exercise or conversion Director acquired 1,030 shares (option exercise)
- 4 Open-market sale Chief Medical Officer sold 259 shares at $7.81 ($2,023)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 254 shares at $6.62 ($1,681)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale General Counsel sold 414 shares at $7.58 ($3,138)
- 4 Open-market sale Chief Financial Officer sold 331 shares at $7.58 ($2,509)
- 4 Open-market sale Chief Medical Officer sold 1,374 shares at $7.58 ($10,415)
- 4 Open-market sale Chief Executive Officer sold 8,195 shares at $7.58 ($62,118)
- 4 Open-market sale Chief Medical Officer sold 111 shares at $8.09 ($898)
- 4 Open-market sale Chief Executive Officer sold 46,968 shares at $9.15 ($429,757)
- 4 Open-market sale General Counsel sold 3,803 shares at $12.03 ($45,750)
- 4 Open-market sale Chief Financial Officer sold 2,587 shares at $12.03 ($31,122)
- 4 Open-market buy Chief Medical Officer bought 160 shares at $13.10 ($2,096)
- 4 Open-market sale Chief Medical Officer sold 258 shares at $17.16 ($4,427)
Page 6 of 12 · 233 filings